Cellular response to synthetic drugs : a metabolomics approach
Propranolol is a nonselective β-blocker of the β-adrenergic receptors, with the S-enantiomer being more active compared with the R-enantiomer. Clinically, it has been shown to be effective in hypermetabolic burn patients by decreasing cardiac work, protein catabolism and lipolysis. While gene expres...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Research Report |
| Language: | English |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/17224 |